(Q36934781)

17 August 2017

1 reference

title

Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis (English)

1 reference

17 August 2017

1 reference

4

Hyeong-Reh Kim

1 reference

17 August 2017

1

R Daniel Bonfil

1 reference

17 August 2017

Sreenivasa Chinni

2

1 reference

17 August 2017

Rafael Fridman

series ordinal

3

1 reference

17 August 2017

Michael L Cher

series ordinal

5

1 reference

17 August 2017

publication date

1 September 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

25

1 reference

17 August 2017

issue

5

1 reference

17 August 2017

page(s)

407-411

1 reference

CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.008

Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.008

Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.008

Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.008

The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.008

Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.008

Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the tumor necrosis factor alpha convertase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.008

PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.008

Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.008

A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.008

10.1016/J.UROLONC.2007.05.008

7 January 2021

Identifiers

DOI

1 reference

17 August 2017

1 reference